Not too long ago we researched and posted about how preemption precludes private plaintiffs from second-guessing FDA decisions on the marketing and classification of the products the Agency regulates. Looking through that post again, we note that quite a few of those decisions (although well less than half) involved commercial disputes of one sort or
Implied Preemption
Partial Preemption Win On Tenuous Claims

The order of operations can matter. Back in elementary school, you may have learned a mnemonic about somebody’s aunt to help you remember the right order for doing certain math problems. In computer programming, engineering, auto repair, surgery, and a myriad of other endeavors, you can get very different results if you take the same…
Short And Sweet Preemption Decision

Long ago, when we first started representing the makers of prescription pharmaceuticals, it was said that people did not tend to sue over life-saving medications. Contraceptives, pain medications, obesity medications, diabetes medications, psychiatric medications, and many others were fair game, even if the risk-benefit calculus for an individual patient might involve major benefits on one…
New York Chantix Case: Great on Preemption, Not So Hot on “Failure to Test.”

Recently, largely related to the dubious pleasure of home ownership, we have had multiple occasions on which we were forced to shrug our shoulders and proclaim, “Nothing’s perfect.” To wit, we recently noticed a small wet spot on our bedroom ceiling. The roofing company discovered that the corresponding section of the roof was too shallow…
Johnson v. Monsanto – Even a Hostile Court Can’t Entirely Deny Preemption

One of the cases we follow closely, with daily searches, is Merck Sharp & Dohme Corp. v. Albrecht, 139 S. Ct. 1668 (U.S. 2019). It’s an implied preemption case, so while we like to think we catch all the drug/device cases anyway, Albrecht can affect preemption in a wide variety of tort situations.
We’d…
“Could This Be the ENDS of Buckman?” Mused The Vaped Crusader

In the ever-extending period of working from home and social distancing, we have spent some time watching various exemplars of the “superhero” genre and noted that the uber kitschy afterschool and weekend morning staple of our youth is not being recreated. (If Stevie Mac is from the Pleistocene, then our youth was in the…
Westward – No!

The recent decision in Mize v. Mentor Worldwide LLC, ___ Cal. Rptr.3d ___, 2020 WL 3602482 (Cal. App. July 2, 2020), demonstrates why California courts – particularly state courts – have such a poor reputation when it comes to product-related litigation. In Mize, a combination of questionable reasoning, together with the state’s absurdly…
More Preemption of Breast Implant Claims

Back in the Pleistocene era when we toiled in law school, it seemed as if modern tort law developed as the result of a cross-continental game of ping pong played between the California and New Jersey courts. That still seems to be the case. Sure, there is the occasional, horrific verdict in flyover country that…
An English Lesson From An Essure Case

Not long ago, an EPL (evil plaintiff lawyer) relayed to us that, based on reading our posts, another EPL had assumed we had a particular political view. As we laughed at the notion, we pondered the issues of assumption and incomplete information. Much like the old quip about what happens when you assume, many assumptions…
Guest Post – E-Gads, Once Again Preemption Prevails In Gadolinium Contrast Litigation

Here’s another guest post by Reed Smith’s Dean Balaes. This one looks into a major (but not too recent) post-Albrecht drug preemption case. Can’t have too many of those! As always, our guest posters deserve all the credit (and any blame) for their writings.
**********
There is no hiding the fact that federal…